Relieva Tract Balloon Dilation System

FDA 510(k) K183090 · Acclarent, Inc.

Substantially Equivalent

510(k) numberK183090

Submission

Device name
Relieva Tract Balloon Dilation System
Applicant
Acclarent, Inc.
Irvin, CA, US
Received
November 6, 2018
Decision date
April 19, 2019
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QGK – Balloon, Nasal Airway
Device class
Class I (low risk)
Regulation
21 CFR 874.4420
Specialty
Ear, Nose, Throat

The nasal airway balloon is intended to provide increased intranasal space to facilitate access for endonasal and transnasal procedures and/or temporarily address nasal obstruction.

More from Acclarent, Inc.

510(k)DeviceDecision
K253612Acclarent AERA Eustachian Tube Balloon Dilation SystemPNZ · Traditional 02/19/2026SE
K230742ACCLARENT AERA Eustachian Tube Dilation SystemPNZ · Traditional 12/13/2023SE
K231862TruDi® Navigation System V3 (FG-2000-00)PGW · Special 07/21/2023SE
K221037TruDi Shaver BladePGW · Traditional 07/20/2022SE
K201115Next Generation Balloon Dilation SystemLRC · Traditional 08/27/2020SE
K201174TruDi CurettePGW · Traditional 08/12/2020SE
K193453TruDi ProbePGW · Traditional 03/23/2020SE
K190532TruDi NAV WirePGW · Traditional 05/03/2019SE
K190525RELIEVA ULTIRRA Sinus Balloon CatheterLRC · Traditional 05/03/2019SE
K180948TruDi NAV Suction InstrumentsPGW · Traditional 07/20/2018SE

Questions and answers

When was Relieva Tract Balloon Dilation System cleared by the FDA?

Relieva Tract Balloon Dilation System (K183090) received a 510(k) decision of Substantially Equivalent on April 19, 2019, 164 days after the submission was received.

What is the product code of K183090?

The FDA product code is QGK – Balloon, Nasal Airway, a Class I (low risk) device regulated under 21 CFR 874.4420.